Company Analysis

Xeris Biopharma Holdings, Inc. (XERS)

Nasdaq: XERS · Pharmaceutical Preparations · Chicago, IL · filing with the SEC since 2021
Grade5.9
◀ Past 7.3● Present 5.4▶ Future 5.1
1 est.

Who owns Xeris Biopharma Holdings, Inc.

As filed with the SEC
Holders of 5% or more
1
Vanguard Capital Management holds 5% of Common Stock, as its SCHEDULE 13G filed Jul 31, 2026 says.
Directors and officers
14
report now, of 19 people on the record since 2021. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 1 named at left.
Holders of 5% or moreshare of the class, as filed
Vanguard Capital Management
5%
The Vanguard Group
SCHEDULE 13G/A · filed Mar 27, 2026 · Common Stock · reported falling below 5%, from 6.74% in Jan 30, 2026
under 5%
What XERS reports owning in othersstakes of 5% or more, and other ties

5 subsidiaries in 4 countries, from the list filed with the 10-K filed Mar 2, 2026.

Insider tradesForm 4
37sales
0purchases
33sales on a scheduled plan
9people selling
$6.1Msold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Nov 6, 2025 to Nov 6, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
212223242526
2026 runs to Nov 6, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window9 of 19 on the roster
PersonRole as filedSalesSoldOn a planBuysBought
Mcculloch KevinSee Remarks8$1.9M80$0
Hecht BethSee Remarks14$1.7M130$0
Johnson Johndirector2$1.1M10$0
Pieper StevenSee Remarks6$600,00060$0
Shannon John Patrick JrChief Executive Officer and Chairman of the Board2$300,00000$0
Bormann-Kennedy Barbara-Jean Annedirector2$200,00020$0
Brady James Aloysiusdirector1$100,00010$0
Halkuff Dawndirector1$100,00010$0
Persky Marladirector1$100,00010$0
SI Assistanton XERS · research, not advice